ArticleCureus2022
Pulmonary Hypertension Associated With Hyperthyroidism: A Case Report.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary hypertension (PH) has various etiologies and its prognosis is unfavorable without appropriate treatment. We report a case in whom hyperthyroidism was considered as a cause of PH. A 32-year-old woman presented with exertional palpitation and dyspnea. Echocardiography showed an estimated systolic pressure in the pulmonary artery of 50 mmHg (reference value, 15 to 30) with no evidence suggestive of congenital heart disease or acquired heart disease. The level of D-dimer was normal and pulmonary perfusion scintigraphy was unremarkable. Thyroid function tests revealed a biochemically hyperthyroid state with elevated anti-thyroid peroxidase antibodies and thyroid stimulating hormone receptor antibodies, findings consistent with Graves' disease. After the administration of treatment with potassium iodide and thiamazole, her symptoms and PH gradually abated and finally disappeared without any specific treatment for PH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.